Our previous study also identified some upregulated genes in both AD and VaD patients, including RhoA, ICAM, AGT, and STAT3, all of which are related to the inflammatory microenvironment in the CNS and could be downregulated by anti-inflammatory therapeutic compounds. This evidence concerns the gene STAT3 and Alzheimer disease.